Skip to main content

MoneyWorks4Me

Natco Pharma informs about disclosure

02 Jul 2019 Evaluate

Natco Pharma has informed about the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Venkata Satya Swathi Kantamani & PACs.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1797.45
Dr. Reddys Labs. 1351.40
Cipla 1371.40
Lupin 1992.60
Zydus Lifesciences 1204.45
View more..